Pacemaker tweak may quietly lower blood pressure without extra pills
NCT ID NCT05086523
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests a special pacemaker called the BackBeat Moderato that can adjust its pacing to help control high blood pressure. Researchers will turn the device on and off for short periods in 28 people who already have the pacemaker implanted, measuring how their blood pressure changes. The goal is to see if the device can safely lower systolic blood pressure when active.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BackBeat Moderato device (programmable hypertension control via pacemaker)
What this could lead to
If it works, this could offer a new way to manage high blood pressure using a pacemaker, potentially reducing the need for daily pills.
What could go wrong
This is a small, early-phase study with only 28 participants, so results may not apply to everyone. The device requires implantation, which carries surgical risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION,ESSENTIAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Na Homolce Hospital
Prague, 15030, Czechia
-
Pomeranian Medical University Hospital no. 2
Szczecin, 70-111, Poland
-
Samodzielnym Publicznym Centralnym Szpitalem Klinicznym
Warsaw, 02-097, Poland
-
Semmelweis University Heart and Vascular Center
Budapest, 1122, Hungary
-
Silesian Center for Heart Diseases
Zabrze, 41-800, Poland
-
Szpital Kliniczny Przemiemienia Panskiego
Poznan, 61-848, Poland